Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]        
Product revenue $ 2,232 $ 1,296 $ 5,265 $ 4,883
Operating costs and expenses:        
Cost of product revenue 774 572 2,018 1,943
Research and product development expenses 298 352 942 1,106
Selling, general and administrative expenses 829 968 2,445 3,025
Operating income (loss) 331 (596) (140) (1,191)
Other expense, net (1) (1) (7) (1)
Income (loss) before income taxes 330 (597) (147) (1,192)
Income tax expense (1) (13) (1) (23)
Net income (loss) $ 329 $ (610) $ (148) $ (1,215)
Income (loss) per share attributable to MTI (Basic) $ .06 $ (.12) $ (.03) $ (.23)
Income (loss) per share attributable to MTI (Diluted) $ .06 $ (.12) $ (.03) $ (.23)
Weighted average shares outstanding (Basic) 5,248,482 5,258,883 5,250,892 5,258,883
Weighted average shares outstanding (Diluted) 5,458,871 5,258,883 5,250,892 5,258,883